Verve Therapeutics Inc. is an innovative biotech company focused on developing new treatments for cardiovascular disease. With a team of experienced scientists and cutting-edge technology, Verve is revolutionizing the field by harnessing the power of gene editing to create targeted therapies. Their mission is to improve patient outcomes and ultimately eliminate the burden of cardiovascular disease.
